TAP is calculated by the percentage of tumor area stained for PD-L1 using the SP263 antibody (Ventana, Roche) including tumor cells and desmoplastic stroma, (membrane staining of any intensity) and tumor-associated immune cells (any intensity) [48]. Here, CD274 is linked to neoplasm.